Brentuximab vedotin plus bendamustine versus platinum-based regimens as 1st salvage therapy and 'bridge' to autologous hematopoietic stem cell transplantation for relapsed/refractory Hodgkin lymphoma.
Panayotis KaloyannidisMohammed Al ZayerMohammed Al DarweeshMajed Al BatranAyed Al GarniAbdulrahman Al NaimHani Al HashmiSolaf KanfarPublished in: Leukemia & lymphoma (2023)